Provision Healthcare at AAPM

By

The American Association of Physicists in Medicine (AAPM), recently celebrated their 60thanniversary! This year’s conference was held in Nashville, Tennessee from July 29th – August 2nd, and Provision Healthcare was an exhibitor. It was a wonderful opportunity to meet medical physicists from around the globe, introducing them to our business and our rich history in innovation.

Provision CARES Proton Therapy Center and RaySearch Laboratories also hosted an exclusive tour on July 30th at the Nashville proton therapy center. The tour showcased Provision Healthcare’s ProNova SC360 Proton Therapy System, along with RaySearch products RayCare and RayStation used for treatment planning at the new center, which is scheduled to begin treating patients later this year! Approximately 75 guests toured the treatment rooms at the facility, enjoyed software demonstrations by RaySearch, and were treated to a guest reception in the lobby.

Photo credits: Jill Preston, RaySearch, and Provision Healthcare

Latest research shows benefit of proton therapy for children with head and neck cancer

By

Thousands of cancer patients have and could benefit from proton therapy, and children definitely top the list.

This week, exciting news has emerged from the renowned Children’s Hospital of Philadelphia confirming that proton therapy effectively treats pediatric cancers of the head and neck and reduces the side effects often experience with conventional radiation treatment.

It’s one more step toward growing and full recognition of proton therapy in the medical community as a state-of-the-art treatment option for cancer. (more…)

Prostate cancer treatment: what you need to know

By

When it comes to prostate cancer treatment, there’s bad news and there’s good news.

The bad news: Prostate cancer ranks the third most common cancer in the U.S. Healthcare providers diagnose more than 200,000 new cases each year. Approximately 14 percent of men will succumb to prostate cancer in their lifetimes. The good news: Most diagnosed with prostate cancer survive. The disease represents 13.3 percent of all new cancer cases. But only 4.7 percent of those diagnosed will die of the disease. Research shows five-year relative survival rates for prostate cancer at 99.7 percent. (National Cancer Institute)

And, proton therapy offers a treatment option for prostate cancer with many fewer short-term and long-term side effects. (more…)

cyclotron, Provision Healthcare, Franklin

Provision installs cyclotron at Nashville site

By

Provision Healthcare in expanding cancer centers and advancing proton therapy to Nashville, TN, with the development of the Provision CARES Cancer Center.

After months of excavating and building construction, The Provision CARES Cancer Center in Franklin, Tenn., welcomed the cyclotron, a key component—and the largest—to the new facility. This brings the center one step closer to treating cancer patients in May 2018. (more…)

Provision dosimetrist ranks with best in planning contest

By

When his boss sent out an email encouraging those in the Provision medical physics department to participate in an international treatment planning competition, Kevin Kirby decided to give it a shot.

Sponsored by ProKnow, a radiation analytics and quality assurance company, the assignment of creating a radiation treatment plan for a head and neck cancer case attracted more than 200 entries.

In the final results, Kirby’s entry ranked 21st among 238 treatment plans, and first among proton therapy entries.

“A perfect score was 150,” said Kirby, a medical dosimetrist at Provision Proton Therapy Center. “I got 144.” The top score was 146.9.

He is the second Provision employee to place high in the ProKnow competition, known as the QADS Plan Study. Samantha Hedrick, a medical physicist, achieved third place out of 124 entries in 2013.

ProKnow develops and sells software to “help improve the standard of care in radiation oncology” through analytical tools and databases that help customers measure and track their planning efforts with a goal of identifying best practices for treating a variety of diseases.

The plan Kirby submitted was scored on a scale of 20+ criteria categories, with the ultimate goal of providing the most dose to the tumor versus the least dose to the surrounding, healthy parts of the body.

Kirby credited his treatment modality, proton therapy, with giving him an edge over competitors using conventional radiation treatment methods.

Proton therapy is particularly suited to treatment of head and neck cancer, because “you are dealing with some very critically sensitive areas to radiation, such as the spine and brain,” Kirby said. “Proton therapy is just one of the top ways to treat one of the most difficult areas to get to in the body.”

“Kevin is an outstanding dosimetrist.  Along with the rest of our staff, Kevin’s knowledge and work ethic has kept Provision’s planning capabilities at the forefront of radiation therapy,” said Ben Robison, Provision director of medical physics.

Kirby’s high score got him a phone interview with ProKnow in which he was asked about his personal background and more details about his planning methods. ProKnow is making the interview available via its website. Ranking so high among other treatment plans is quantitative validation that proton therapy and, specifically, the medical care at Provision, is best-in-class, he said.

“There’s a lot of hyperbole,” Kirby said. “This is a blind, metric product that shows our treatment is one of the best in the world. It just validates what we’re doing here.”